[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Kymera
Kymera Therapeutics announced the closing of an upsized $XXX million public offering and the full exercise of underwriters' option to purchase additional shares. This follows positive results from their BroADen Phase 1b clinical trial of KT-621.
About Kymera
Kymera Therapeutics is a biotechnology company focused on developing targeted protein degradation therapies.
Insights
- kymera sentiment is up XXXXX% from the previous month.
- kymera creators is up XXXXXX% from the previous year.
- kymera engagements is up XXXXXX% from the previous X months.
- kymera mentions is up XXXXXX% from the previous X months.
- kymera posts created is up XXXXXX% from the previous X months.
- kymera Mentions hit a 52-Week high of XXX for the day
- kymera Mentions hit an all time of XXX for the day
Engagements: XXXXXX (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXXX
Daily Average: XXXXX
X Week: XXXXXXX +71%
X Month: XXXXXXX +27%
X Months: XXXXXXXXX +75%
X Year: XXXXXXXXX -XX%
1-Year High: XXXXXX on 2025-05-02
1-Year Low: XX on 2025-02-18
Engagements by network (24h): News: XX Reddit: XXX TikTok: XXXXX X: XXXXX YouTube: XXXXX
Mentions: XXX (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XX
X Week: XXX +35%
X Month: XXX +13%
X Months: XXXXX +273%
X Year: XXXXX +223%
1-Year High: XXX on 2025-12-10
1-Year Low: X on 2025-05-17
Mentions by network (24h): News: XX Reddit: XXX TikTok: XXX X: XXX YouTube: XX
Creators: XXX (24h)
Creators 24-Hour Time-Series Raw Data
XXX unique social accounts have posts mentioning Kymera in the last XX hours which is down XX% from XXX in the previous XX hours
Daily Average: XX
X Week: XXX +30%
X Month: XXX +29%
X Months: XXX +180%
X Year: XXX +181%
1-Year High: XXX on 2025-09-29
1-Year Low: X on 2025-05-24
The most influential creators that mention Kymera in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @kymerajennette | X | XXX | XX | XXXXX |
| @unisam71 | X | XXX | X | XXX |
| @hybrido | X | XXXXX | X | XXX |
| @hybridokymera | X | XXX | X | XXX |
| @monaco_biotech | X | XXXXX | X | XXX |
| @KymeraTx | X | XXXXX | X | XXX |
| @lifesciencerpt | X | XXXXX | X | XXX |
| @allday_stocks | X | XXXXX | X | XXX |
| @kymerekal | X | XXX | X | XXX |
| @EpicNerd99 | XX | X | XX |
Sentiment: XX%
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
X Week: XX% +7%
X Month: XX% +14%
X Months: XX% +9%
X Year: XX% +5%
1-Year High: XXX% on 2024-12-29
1-Year Low: XX% on 2025-03-24
Most Supportive Themes:
- Partnerships and Potential: (60%) Kymera Therapeutics has established partnerships with major companies like Gilead and Sanofi, indicating potential for growth.
- Industry Growth: (25%) Kymera is part of a group of biotech companies expected to experience growth and innovation.
Most Critical Themes:
- Valuation Concerns: (15%) Questions have been raised about Kymera's valuation, especially given its pre-clinical assets.
Top Kymera News
Top news links shared on social in the last XX hours
Showing a maximum of X news posts for non-authenticated requests. Use your API key in requests for full results.
"Kymera Therapeutics raises $602M after clinical trial win - Boston Business Journal"
News Link @bizjournals 2025-12-10T20:13Z 228.6M followers, XXX engagements
"Kymera Therapeutics stock price target raised to $XXX from $XX at Stifel By Investing.com"
News Link @Investingcom 2025-12-08T22:11Z 1.4M followers, XXX engagements
"Kymera Therapeutics Announces Positive Results from BroADen Phase 1b Clinical Trial of KT-621 a First-in-Class Oral STAT6 Degrader in Patients with Moderate to Severe Atopic Dermatitis"
News Link @YahooFinance 2025-12-08T12:06Z 228.6M followers, 19.4K engagements
Top Kymera Social Posts
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"Yep: heres a summary of the footnotes though. Baker Brothers two funds bought about X million shares of Kymera at $XX each. The Bakers manage the funds and may have an indirect financial interest but they formally disclaim ownership of the shares. Felix Baker is on Kymeras board which makes the other managers count as directors by association under SEC rules"
X Link @BeatTheInsider 2025-12-11T21:49Z 11.3K followers, XX engagements
"$KYMR - Kymera Therapeutics Announces Closing of Upsized $XXX Million Public Offering and Full Exercise of Underwriters Option to Purchase Additional Shares"
X Link @tenet_research 2025-12-11T21:05Z 449.6K followers, XXX engagements
"$KYMR -XXXX% today as Kymera Therapeutics Announces U.S. FDA Fast Track Designation for KT-621 a First-in-Class Oral STAT6 Degrader for the Treatment of Atopic Dermatitis More Info:"
X Link @OzmosiHealth 2025-12-11T17:37Z 3017 followers, XX engagements
"JUST IN: $KYMR Kymera Therapeutics Announces U.S. FDA Fast Track Designation for KT-621 a First-in-Class Oral STAT6 Degrader for the Treatment of Atopic Dermatitis @grok please provide the finance card for $KYMR"
X Link @marketwirenews 2025-12-11T16:40Z 60.7K followers, XXX engagements